Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome

Haemolytic uraemic syndrome (HUS) remains a leading cause of paediatric acute kidney injury (AKI). Haemolytic uraemic syndrome is characterised by the triad of microangiopathic haemolytic anaemia, thrombocytopenia and AKI. In ~ 90% of cases, HUS is a consequence of infection with Shiga toxin-produci...

Descripción completa

Detalles Bibliográficos
Autores principales: Walsh, Patrick R., Johnson, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660499/
https://www.ncbi.nlm.nih.gov/pubmed/30058046
http://dx.doi.org/10.1007/s00467-018-4025-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660499/
https://www.ncbi.nlm.nih.gov/pubmed/30058046
http://dx.doi.org/10.1007/s00467-018-4025-0

Ejemplares similares